STEVEN B RATOFF
CIK 1054941 · President and CEO · last filed 2023-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.14M
Companies
2
Total Filings
32
Lifetime Open-Market Net
-$458.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 22,684 | $2.14 | $48.5K | -$699.6K | 16 | 2023-03-09 |
| NVD | Chief Executive Officer | 823,866 | $5.02 | $4.14M | $241.3K | 13 | 2009-12-14 |
Recent Filings · Page 2 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-14 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | −6,050 | -$699.6K | EDGAR |
| 2016-01-05 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-22 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-17 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-20 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Conv (C) | +10,014 | $0 | EDGAR |
| 2010-01-07 | — | Grant (A) | — | $0 | |
| 2009-12-14 | NVD | Buy (P) | +1,000,000 | $159.2K | EDGAR |
| 2009-10-21 | NVD | Grant (A) | — | $0 | EDGAR |
| 2009-10-19 | NVD | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.